Brechmann Thorsten, Mühlenkamp Maximilian, Schmiegel Wolff, Viebahn Bernd
Department of Gastroenterology and Hepatology, Berufsgenossenschaftliche Universitätsklinik Bergmannsheil Bochum gGmbH, Ruhr-University Bochum, Bürkle-de-La-Camp-Platz 1, 44789, Bochum, Germany.
Department of Internal Medicine and Gastroenterology, St. Elisabeth Hospital, Stadtring Kattenstroth 130, 33332, Gütersloh, Germany.
Dig Dis Sci. 2023 May;68(5):1936-1943. doi: 10.1007/s10620-022-07745-9. Epub 2022 Nov 14.
Argon plasma coagulation (APC) of gastric inlet patches of the cervical esophagus (GIP) has been shown to relieve the globus sensation. This study aimed to investigate the long-term effects of APC therapy on a variety of laryngopharyngeal symptoms.
Patients with laryngopharyngeal symptoms who had undergone endoscopic GIP eradication via APC therapy were eligible for a retrospective observational cohort study. Symptom relief was assessed by a five-grade scale during a structured interview. Statistical analysis included ANOVA, the chi-squared and t-test.
A total of 45 patients (61.0 (52.0; 69.0) years, 26 (57.8%) female) were included after a follow-up time of 85.0 (55.3; 111.0) months. Symptoms included dysphagia (56.0%), dysphonia (51.0%), hoarseness (76.0%), the necessity of throat clearing (73.0%), globus sensation (56.0%) and heartburn (71.0%). Complete GIP eradication was achieved after one session in 25 (55.6%), repetitive sessions were needed in the remaining cases. Fourteen patients (31.1%) reported a very strong, 11 (24.4%) a strong and 8 patients (17.8%) an intermediate improvement; five patients did not benefit. The most apparent improvement was seen regarding hoarseness (from 2.6 ± 1.7 to 1.2 ± 1.3), the necessity of throat clearing (from 2.6 ± 1.7 to 1.1 ± 1.3), globus sensation (from 2.0 ± 1.9 to 0.9 ± 1.3) and heartburn (from 2.5 ± 1.8 to 1.4 ± 1.6). Adverse events included post-endoscopic pain (n = 6, 13.3%) and purulent pharyngitis (n = 2, 4.4%).
The APC therapy of GIP is safe and leads to long-term relief of laryngopharyngeal symptoms in carefully selected patients.
已证实氩等离子体凝固术(APC)治疗颈段食管胃入口斑(GIP)可缓解咽部异物感。本研究旨在探讨APC治疗对多种咽喉部症状的长期影响。
接受APC治疗内镜下根除GIP的咽喉部症状患者符合一项回顾性观察队列研究的条件。在结构化访谈中通过五级量表评估症状缓解情况。统计分析包括方差分析、卡方检验和t检验。
在85.0(55.3;111.0)个月的随访期后,共纳入45例患者(年龄61.0(52.0;69.0)岁,26例(57.8%)为女性)。症状包括吞咽困难(56.0%)、发音障碍(51.0%)、声音嘶哑(76.0%)、清嗓需求(73.0%)、咽部异物感(56.0%)和烧心(71.0%)。25例(55.6%)患者一次治疗后实现GIP完全根除,其余患者需要重复治疗。14例患者(31.1%)报告有非常明显的改善,11例(24.4%)有明显改善,8例患者(17.8%)有中度改善;5例患者未获益。声音嘶哑(从2.6±1.7降至1.2±1.3)、清嗓需求(从2.6±1.7降至1.1±1.3)、咽部异物感(从2.0±1.9降至0.9±1.3)和烧心(从2.5±1.8降至1.4±1.6)方面改善最为明显。不良事件包括内镜检查后疼痛(n = 6,13.3%)和脓性咽炎(n = 2,4.4%)。
在精心挑选的患者中,GIP的APC治疗是安全的,并能长期缓解咽喉部症状。